Studies immune system and skin healing in immune-related skin conditions
Compares immune and skin samples in people with immune deficiency, eczema, or psoriasis.
Key facts
- Who runs it
- National Institute of Allergy and Infectious Diseases (NIAID)
- Where
- Bethesda, United StatesSee the site
- Trial code
- Registry title
- Metabolic Profiling of Immune Responses in Immune-mediated Diseases
- Status
- Recruiting
- People taking part
- 300 people, planned
- Started
- 10 Aug 2021
- Expected to end
- 30 Jun 2027
- Type of study
- Observational, 4 groups
- Record updated
- 3 November 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with a primary immune deficiency, eczema (atopic dermatitis) or psoriasis. Healthy volunteers can also join.
- Age
- 18 to 75 years
- Sex
- All sexes can join.
- Disease stage
- Confirmed or suspected primary immune deficiency, psoriasis or atopic dermatitis diagnosed by a doctor, or no sign of these conditions (healthy volunteers).
- Earlier treatment
- No blood thinner or anti-platelet treatment in the last 3 months, other than aspirin or non-steroidal anti-inflammatory drugs. No immune-modifying drugs (for example chemotherapy or steroids) in the last 3 months, unless the principal investigator approves.
- Biomarker or test result
- For confirmed primary immune deficiency: a harmful gene variant known to be linked to immune deficiency. For suspected primary immune deficiency: a gene variant of unclear significance predicted to harm immune function, or more frequent, longer-lasting or more severe infections than normal.
Main reasons for not taking part
- Blood thinner or anti-platelet treatment now or in the last 3 months (aspirin and NSAIDs are allowed)
- Immune-modifying drugs such as chemotherapy or steroids now or in the last 3 months, unless approved
- History of keloid (raised scar) formation
- Pregnancy, lactating or breastfeeding
- Any condition the investigator thinks makes joining unsafe
The registry criteria, word for word
Show all 11 criteriaShow less
Who cannot take part
- Current or prior (within 3 months) use of immunomodulatory drugs (eg, chemotherapy, steroids), except if approved by the principal investigator
- History of keloid formation
- Any condition that, in the opinion of the investigator, contraindicates participation in the study; Co-enrollment guidelines: Participants may be co-enrolled in other studies; however, study staff should be notified of co-enrollment
- Current or prior (within 3 months) anticoagulant or anti-platelet therapy (other than aspirin or non-steroidal anti-inflammatory drugs)
- An individual who meets any of the following criteria will be excluded from participation in this study:
- Pregnancy, lactating, or breastfeeding
Other criteria
- INCLUSION CRITERIA:; In order to be eligible to participate in this study, an individual must meet all of the following criteria:
- Meets one of the following:; Has documentation of PID confirmed by genetic evaluation demonstrating a deleterious variant in the gene (or genes) known to be associated with immune deficiency (confirmed PID); or; Has documented variant of undetermined significance in a gene (or genes) that is predicted to be deleterious in immune function by the investigators OR a clinical history of infections which are more frequent, more chronic, or more severe than normal (suspected PID); or; Has physician-diagnosed psoriasis; or; Has physician-diagnosed AD; or; Does not have clinically apparent evidence of any monogenic or digenic immune defect, AD, or psoriasis (healthy volunteers)
- Aged 18 to 75 years
- Willing to allow storage of blood, biopsy tissue, bacterial and fungal cultures, and any other samples collected for future research
- Able to provide informed consent
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
Where in United States
- National Institutes of Health Clinical CenterBethesda, United StatesContact: Jodi L Blake, R.N.Taking people
About the trial
What the trial wants to find out
Background:
Read full original descriptionShow less
The immune system is the part of the body that fights infection. Some people have immune deficiencies that cause skin rashes, make them get sick often with infections, or make it difficult for their skin to heal. Researchers want to learn more to better treat conditions that affect immune response.
Objective:
To learn about how the immune system and skin healing are related to each other.
Eligibility:
People ages 18-75 with primary immune deficiency, eczema, or psoriasis. Healthy volunteers are also needed.
Design:
Participants will be screened with a medical and medicine history and a physical exam. They may take a pregnancy test.
Participants will discuss the medicines or supplements they take as well as skin products they use, such as soaps and lotions.
Participants will have up to 4 skin biopsies taken from the forearm. A needle will inject an anesthetic into the skin where the biopsy will be done. A sharp tool that looks like a tiny cookie cutter will be used to remove a round plug of skin a bit smaller than the tip of a pencil.
Participants will give at least 1 blood sample.
Participants may have optional skin swab collection. A cotton swab will be used to swab the skin on the arm.
Participants may have optional skin tape collection. A sticky strip of tape will be placed on the arm and then removed.
Participants may give leftover samples taken as part of their regular medical care.
Participation will last for about 4 days. Participants will have 2 visits that each last about 1 hour. They may be asked to repeat the study in the future.
The 4 groups in the trial
- Healthy volunteers
Control group
- Patients with atopic dermatitis
Physician-diagnosed atopic dermatitis
- Patients with primary immunodeficiency
Confirmed by genetic diagnosis or suspected by genetic variant of unconfirmed significance and a history consistent with immunodeficiency
- Patients with psoriasis
Physician-diagnosed psoriasis
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Metabolic Profiling of Immune Responses in Immune-Mediated Diseases
- Plain-language title
- Studies immune system and skin healing in immune-related skin conditionsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT04864886, who can take part
- Record updated
- 3 November 2026